GlassScriptPhysician profile
Brian A Braithwaite
NPI 1992090138
$8,513.96
in general payments reported to CMS, 2019-2025
31 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,419 · 2020: $1,071 · 2021: $1,104 · 2022: $940 · 2023: $692 · 2024: $77.16 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $980.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $979.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,093.22 | 2019 | |
| Abbott Laboratories | $1,660.47 | 2019-2023 | Proclaim |
| Boston Scientific Corporation | $1,632.61 | 2019-2023 | |
| Vertos Medical, INC. | $845.13 | 2021-2023 | Mild Device Kit |
| Tepha INC | $782.16 | 2019-2020 | |
| Medtronic, INC. | $327.82 | 2021-2025 | Intellis Adaptivestim |
| Stimwave Technologies Incorporated | $131.13 | 2022 | |
| Biodelivery Sciences International, INC. | $114.07 | 2019-2021 | |
| Abbvie INC. | $94.74 | 2021-2023 | Qulipta |
| Biotronik Nro, INC. | $93.51 | 2025 | Prospera |
| Innovation Technologies INC | $81.91 | 2024-2025 | Irrisept |
| Scilex Pharmaceuticals INC. | $79.61 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $74.65 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $55.47 | 2019-2020 | |
| Daiichi Sankyo INC. | $38.08 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $36.79 | 2021 | |
| Amgen INC. | $36.58 | 2019 | |
| Allergan, INC. | $35.99 | 2022 | |
| Grt US Holding, INC. | $35.39 | 2021 | |
| Protega Pharmaceutials INC | $33.70 | 2022 | |
| Mentor Worldwide LLC | $31.47 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $29.59 | 2019-2020 | |
| Spinefrontier, INC. | $27.24 | 2020 | |
| Assertio Therapeutics, INC. | $26.24 | 2020 | |
| Acera Surgical, INC. | $22.99 | 2024 | Restrata Wound Matrix |
| Molnlycke Health Care US, LLC | $22.26 | 2024 | Mepilex Border Post-Op Ag |
| Pacira Pharmaceuticals Incorporated | $17.74 | 2025 | Exparel |
| Tersera Therapeutics LLC | $16.20 | 2019 | |
| Averitas Pharma INC. | $15.97 | 2023 | Qutenza |
| Horizon Therapeutics Plc | $10.86 | 2019 | |
| Spr Therapeutics, INC | $10.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Braithwaite listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.